222 related articles for article (PubMed ID: 32438245)
1. Immune response and onset of protection from Bovine viral diarrhea virus 2 infection induced by modified-live virus vaccination concurrent with injectable trace minerals administration in newly received beef calves.
Bittar JHJ; Palomares RA; Hurley DJ; Hoyos-Jaramillo A; Rodriguez A; Stoskute A; Hamrick B; Norton N; Adkins M; Saliki JT; Sanchez S; Lauber K
Vet Immunol Immunopathol; 2020 Jul; 225():110055. PubMed ID: 32438245
[TBL] [Abstract][Full Text] [Related]
2. Clinical status and endoscopy of the upper respiratory tract of dairy calves infected with Bovine viral diarrhea virus 2 and Bovine herpes virus 1 after vaccination and trace minerals injection.
Hoyos-Jaramillo A; Palomares RA; Bittar JH; Divers SJ; Chamorro MF; Berghaus R; Kirks SJ; Rush J; Edmondson M; Rodriguez A; Gonzalez-Altamiranda EA
Res Vet Sci; 2022 Dec; 152():582-595. PubMed ID: 36201905
[TBL] [Abstract][Full Text] [Related]
3. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
[TBL] [Abstract][Full Text] [Related]
4. Effects of injectable trace minerals administered concurrently with a modified live virus vaccine on long-term protection against bovine viral diarrhea virus acute infection in dairy calves.
Bittar JHJ; Hoyos-Jaramillo A; Hurley DJ; Woolums AR; Havenga LJ; Lourenço JM; Barnett G; Gomes V; Saliki JT; Harmon DD; Palomares RA
Res Vet Sci; 2018 Aug; 119():250-258. PubMed ID: 30036856
[TBL] [Abstract][Full Text] [Related]
5. Effect of injectable trace minerals on the humoral immune response to multivalent vaccine administration in beef calves.
Arthington JD; Havenga LJ
J Anim Sci; 2012 Jun; 90(6):1966-71. PubMed ID: 22178855
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the stress-reducing effect of trace mineral injection in beef calves.
Megahed AA; Bittar JHJ; Palomares RA; Mercadante VRG; Dias NW
J Vet Intern Med; 2023; 37(3):1278-1285. PubMed ID: 37186325
[TBL] [Abstract][Full Text] [Related]
7. Effect of calf age and administration route of initial multivalent modified-live virus vaccine on humoral and cell-mediated immune responses following subsequent administration of a booster vaccination at weaning in beef calves.
Woolums AR; Berghaus RD; Berghaus LJ; Ellis RW; Pence ME; Saliki JT; Hurley KA; Galland KL; Burdett WW; Nordstrom ST; Hurley DJ
Am J Vet Res; 2013 Feb; 74(2):343-54. PubMed ID: 23363363
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the immune response following subcutaneous versus intranasal modified-live virus booster vaccination against bovine respiratory disease in pre-weaning beef calves that had received primary vaccination by the intranasal route.
Palomares RA; Bittar JHJ; Woolums AR; Hoyos-Jaramillo A; Hurley DJ; Saliki JT; Ferrer MS; Bullington AC; Rodriguez A; Murray T; Thoresen M; Jones K; Stoskute A
Vet Immunol Immunopathol; 2021 Jul; 237():110254. PubMed ID: 34034143
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of shedding of bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 after vaccination of calves with a multivalent modified-live virus vaccine.
Kleiboeker SB; Lee SM; Jones CA; Estes DM
J Am Vet Med Assoc; 2003 May; 222(10):1399-403. PubMed ID: 12762386
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
[TBL] [Abstract][Full Text] [Related]
11. Antibody titers to vaccination are not predictive of level of protection against a BVDV type 1b challenge in Bos indicus - Bos taurus steers.
Downey-Slinker ED; Ridpath JF; Sawyer JE; Skow LC; Herring AD
Vaccine; 2016 Sep; 34(42):5053-5059. PubMed ID: 27601344
[TBL] [Abstract][Full Text] [Related]
12. In vitro neutralization of HoBi-like viruses by antibodies in serum of cattle immunized with inactivated or modified live vaccines of bovine viral diarrhea viruses 1 and 2.
Bauermann FV; Harmon A; Flores EF; Falkenberg SM; Reecy JM; Ridpath JF
Vet Microbiol; 2013 Sep; 166(1-2):242-5. PubMed ID: 23764273
[TBL] [Abstract][Full Text] [Related]
13. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of multivalent, modified- live virus (MLV) vaccines administered to early weaned beef calves subsequently challenged with virulent Bovine viral diarrhea virus type 2.
Chamorro MF; Walz PH; Passler T; van Santen E; Gard J; Rodning SP; Riddell KP; Galik PK; Zhang Y
BMC Vet Res; 2015 Feb; 11():29. PubMed ID: 25880998
[TBL] [Abstract][Full Text] [Related]
15. Response of calves persistently infected with noncytopathic bovine viral diarrhea virus (BVDV) subtype 1b after vaccination with heterologous BVDV strains in modified live virus vaccines and Mannheimia haemolytica bacterin-toxoid.
Fulton RW; Step DL; Ridpath JF; Saliki JT; Confer AW; Johnson BJ; Briggs RE; Hawley RV; Burge LJ; Payton ME
Vaccine; 2003 Jun; 21(21-22):2980-5. PubMed ID: 12798641
[TBL] [Abstract][Full Text] [Related]
16. Maternally derived humoral immunity to bovine viral diarrhea virus (BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza-3 virus bovine respiratory syncytial virus, Mannheimia haemolytica and Pasteurella multocida in beef calves, antibody decline by half-life studies and effect on response to vaccination.
Fulton RW; Briggs RE; Payton ME; Confer AW; Saliki JT; Ridpath JF; Burge LJ; Duff GC
Vaccine; 2004 Jan; 22(5-6):643-9. PubMed ID: 14741155
[TBL] [Abstract][Full Text] [Related]
17. Fetal protection against bovine viral diarrhea virus types 1 and 2 after the use of a modified-live virus vaccine.
Xue W; Mattick D; Smith L; Maxwell J
Can J Vet Res; 2009 Oct; 73(4):292-7. PubMed ID: 20046631
[TBL] [Abstract][Full Text] [Related]
18. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
[TBL] [Abstract][Full Text] [Related]
19. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
[TBL] [Abstract][Full Text] [Related]
20. Clinical and microbiological effects in high-risk beef calves administered intranasal or parenteral modified-live virus vaccines.
Powledge SA; McAtee TB; Woolums AR; Robin Falkner T; Groves JT; Thoresen M; Valeris-Chacin R; Richeson JT
J Anim Sci; 2022 Nov; 100(11):. PubMed ID: 35926833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]